Neuralink and NEO: Brain-Computer Interface Implants Begin Human Trials

While the technology promises to revolutionize treatment for people with disabilities, it also raises ethical and practical concerns.

Elon Musk's Neuralink has begun human trials with its first patient, a quadriplegic, receiving a brain implant that allows them to control a computer with their thoughts.
Chinese scientists at Tsinghua University have also developed a brain-computer interface implant, called the Neural Electronic Opportunity (NEO), which has helped a quadriplegic patient regain mobility.
Both Neuralink and NEO are being touted as potential game-changers for people with disabilities, with applications ranging from restoring mobility to controlling epilepsy.
However, the Physicians Committee for Responsible Medicine has expressed concerns about Neuralink's lack of transparency and past unethical animal testing.
Despite the progress, experts caution that the technology is still in its early stages and raises a myriad of ethical and practical concerns.